Keywords: GlaxoSmithKline GSK, WHO, Synflorix pneumococcal conjugate vaccine
WHO grants prequalification for GlaxoSmithKline’s 10-Valent Synflorix vaccine
Article | 09 November 2009
The World Health Organization has awarded prequalification for global use to GlaxoSmithKline’s Synflorix pneumococcal conjugate vaccine. The prequalification is ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
